1. Home
  2. GFR vs SAGE Comparison

GFR vs SAGE Comparison

Compare GFR & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFR
  • SAGE
  • Stock Information
  • Founded
  • GFR 2018
  • SAGE 2010
  • Country
  • GFR Canada
  • SAGE United States
  • Employees
  • GFR N/A
  • SAGE N/A
  • Industry
  • GFR
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFR
  • SAGE Health Care
  • Exchange
  • GFR Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • GFR 423.8M
  • SAGE 415.0M
  • IPO Year
  • GFR N/A
  • SAGE 2014
  • Fundamental
  • Price
  • GFR $5.01
  • SAGE $7.68
  • Analyst Decision
  • GFR Buy
  • SAGE Hold
  • Analyst Count
  • GFR 1
  • SAGE 19
  • Target Price
  • GFR $10.50
  • SAGE $9.88
  • AVG Volume (30 Days)
  • GFR 116.3K
  • SAGE 1.3M
  • Earning Date
  • GFR 05-14-2025
  • SAGE 04-29-2025
  • Dividend Yield
  • GFR N/A
  • SAGE N/A
  • EPS Growth
  • GFR N/A
  • SAGE N/A
  • EPS
  • GFR 1.18
  • SAGE N/A
  • Revenue
  • GFR $549,712,963.00
  • SAGE $41,243,000.00
  • Revenue This Year
  • GFR $3.00
  • SAGE $100.39
  • Revenue Next Year
  • GFR $2.28
  • SAGE $70.86
  • P/E Ratio
  • GFR $4.27
  • SAGE N/A
  • Revenue Growth
  • GFR 21.26
  • SAGE N/A
  • 52 Week Low
  • GFR $4.36
  • SAGE $4.62
  • 52 Week High
  • GFR $8.16
  • SAGE $14.97
  • Technical
  • Relative Strength Index (RSI)
  • GFR 45.45
  • SAGE 54.41
  • Support Level
  • GFR $4.85
  • SAGE $7.27
  • Resistance Level
  • GFR $5.22
  • SAGE $7.64
  • Average True Range (ATR)
  • GFR 0.42
  • SAGE 0.39
  • MACD
  • GFR 0.02
  • SAGE 0.03
  • Stochastic Oscillator
  • GFR 38.01
  • SAGE 84.20

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: